Adagio Medical Holdings, Inc Common Stock (ADGM) - Total Liabilities
Based on the latest financial reports, Adagio Medical Holdings, Inc Common Stock (ADGM) has total liabilities worth $32.86 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Adagio Medical Holdings, Inc Common Stoc operating cash flow efficiency to assess how effectively this company generates cash.
Adagio Medical Holdings, Inc Common Stock - Total Liabilities Trend (2020–2024)
This chart illustrates how Adagio Medical Holdings, Inc Common Stock's total liabilities have evolved over time, based on quarterly financial data. Check ADGM asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Adagio Medical Holdings, Inc Common Stock Competitors by Total Liabilities
The table below lists competitors of Adagio Medical Holdings, Inc Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Archtis Ltd
AU:AR9
|
Australia | AU$15.84 Million |
|
Elevation Oncology Inc
NASDAQ:ELEV
|
USA | $35.49 Million |
|
Gillanders Arbuthnot & Company Limited
NSE:GILLANDERS
|
India | Rs2.75 Billion |
|
Nyesa Valores Corp SA
MC:NYE
|
Spain | €30.88 Million |
|
Ocean Vantage Holdings Bhd
KLSE:0220
|
Malaysia | RM36.40 Million |
|
MIND CTI Ltd
NASDAQ:MNDO
|
USA | $7.18 Million |
|
NanoViricides Inc
NYSE MKT:NNVC
|
USA | $1.18 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Adagio Medical Holdings, Inc Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Adagio Medical Holdings, Inc Common Stoc stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.84 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -25.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Adagio Medical Holdings, Inc Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Adagio Medical Holdings, Inc Common Stock (2020–2024)
The table below shows the annual total liabilities of Adagio Medical Holdings, Inc Common Stock from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $28.54 Million | -79.45% |
| 2023-12-31 | $138.85 Million | +32.77% |
| 2022-12-31 | $104.57 Million | +11.18% |
| 2021-12-31 | $94.06 Million | +167885.86% |
| 2020-12-31 | $55.99K | -- |
About Adagio Medical Holdings, Inc Common Stock
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablat… Read more